Developer of drug candidates for the treatment of hypertension and epilepsy. The company's drug candidates are based on novel no-donor compounds that do not evoke pro-drug tolerance.
What you see here scratches the surface
We’ll help you find what you need
Ready to get started?
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.